Despite the strong gains on Friday I’m still on double-top watch for the S&P 500. It’s still just teasing the all time high set in July. (and the volume is still unimpressive… but we won’t talk about that until it actually matters…)
On Today’s Calendar:
- nothing
More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
On weak earnings/guidance: R -6.3%… Other news: NOVN -21.8% (announces a Phase 3 study lithium carbonate product did not meet its primary endpoint), LDK -11.2% (mentioned negatively in Barron’s — CSIQ -4.9%, JASO -4%, SOLF -3.7% trading lower in sympathy), SAP -6% (acquires BOBJ, expects transaction to be dilutive by mid single digits EUR cents in 2008), EMKR -4.2% (receives notice from NASDAQ regarding the co’s 2006 annual meeting of shareholders), EPEX -3.9% (logged a total of 18 wells in the third quarter), PTR -3.8% (Berkshire cuts ownership stake to 6.97%).
Gapping Up
Gapping up on strong earnings/guidance: CTDC +29.3% (co issues press release with previously reported 1H results (originally reported Fri morning), provides additional commentary)… M&A: NGPS +16.1% (to be acquired by Hexagon for $50 per share), BOBJ +15.1% (to be acquired by SAP for ~$59.64 per ADS — secondary plays COGN +6.2%, INFA +2.6%, MSTR +2.6% are trading higher in pre-mkt), UIC +5.8% (to be acquired by Textron for $81/share)… Select China names are bid up in pre-market trading: XFML +22.0% (hearing early strength attributed to newsletter mention), HRAY +16.4%, CDS +9.9%, CNTF +8.6% (announces the launch of the world’s first WCDMA/GSM dual mode phone), CLWT +8.5%, STV +7.5% (stock had its IPO on Friday), CPSL +7.0%, ATS +6.6%, ORS +6.3%… Other news: AVNR +29.3% (granted special protocol assessment from FDA for confirmatory phase III trial of Zenvia in patients with P.B.A.), UCBH +14.3% (signs agreement for China Minsheng Banking to take minority strategic investment), MASI (Cramer names stock as an overlooked IPO), CHDX +7.5% (tgt raised to $38 at Brean Murray, saying co has been selected as the preferred 2008 Beijing Olympics healthcare service provider), HEPH +5.5% (presents positive data demonstrating HE3286 provides benefit in animal model of ulcerative colitis).
Disclaimer & How I use this list
